Who is sponsoring NCT03457129?

NCT03457129 is sponsored by University of Arizona.

What drugs are being tested in NCT03457129?

Interventions: Perampanel Oral Tablet.

What is the status of NCT03457129?

NCT03457129 is currently COMPLETED.

Last reviewed 2023-08-15 · How we verify

Fycompa Titration Intervals and Effects on Retention Rate

NCT03457129 PHASE4 COMPLETED Results posted

This study will aim to improve retention and tolerability by slowing the initial titration rate of perampanel from a standard up-titration rate of 2 week intervals to a slower up-titration rate consisting of 3 week intervals. Subjects will be randomized to either perampanel, standard titration interval rate (Group A) or perampanel, slower titration interval rate (Group B).

Details

Lead sponsor	University of Arizona
Phase	PHASE4
Status	COMPLETED
Enrolment	20
Start date	Wed Apr 18 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Wed Dec 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Epilepsy

Interventions

Perampanel Oral Tablet

Countries

United States